Koyfin Home > Directory > Health Care > Adma Biologics > Issuance of Common Stock

Adma Biologics Issuance of Common Stock Chart (ADMA)

Adma Biologics annual/quarterly Issuance of Common Stock from 2012 to 2020.
  • Adma Biologics Issuance of Common Stock for the quarter ending September 09, 2020 was $11m a 100.00% increase of 11m year over year
  • Adma Biologics Issuance of Common Stock for the last 12 months ending September 09, 2020 was $99m a 51.21% increase of 51m year over year
  • Adma Biologics Annual Issuance of Common Stock for 2019 was $48m a 11.38% increase of 6m from 2018
  • Adma Biologics Annual Issuance of Common Stock for 2018 was $43m a 8.73% increase of 4m from 2017
  • Adma Biologics Annual Issuance of Common Stock for 2017 was $39m a 67.10% increase of 26m from 2016
Other Cash Flow Metrics:
  • Adma Biologics Cash Flow from Operations for the quarter ending December 12, 2018 was $-19m a 12.55% decrease of -2m year over year
  • Adma Biologics Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-14m a 28.03% decrease of -4m year over year
  • Adma Biologics Total Revenue for the quarter ending September 09, 2018 was $4m a -183.74% decrease of -8m year over year
View Chart On Koyfin

Quarterly ADMA Issuance of Common Stock Data

09/2020$11m
06/2020$0m
03/2020$89m
12/2019$0m
09/2019$0m
06/2019$48m
12/2018$0m
09/2018$0m
06/2018$43m
12/2017$39m

Annual ADMA Issuance of Common Stock Data

2019$48m
2018$43m
2017$39m
2016$13m
2015$10m
2013$27m
2012$17m